Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3649-3649
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 690
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease
Min Yu, Xiaoyuan Wei, Zhigong Wei, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 27
Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
Adina Chiş, Paul Aimé Noubissi, Oana Lelia Pop, et al.
Plants (2023) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 26
Pump‐Less, Recirculating Organ‐on‐Chip (rOoC) Platform to Model the Metabolic Crosstalk between Islets and Liver
Aleksandra Aizenshtadt, Chencheng Wang, Shadab Abadpour, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 13
Open Access | Times Cited: 10
PFHxS Exposure and the Risk of Non-Alcoholic Fatty Liver Disease
Zulvikar Syambani Ulhaq, William Ka Fai Tse
Genes (2024) Vol. 15, Iss. 1, pp. 93-93
Open Access | Times Cited: 8
Bio inspired heuristic computing scheme for the human liver nonlinear model
Zulqurnain Sabir, Salem Ben Saïd, Qasem M. Al‐Mdallal
Heliyon (2024) Vol. 10, Iss. 7, pp. e28912-e28912
Open Access | Times Cited: 8
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease
Alessandra Colantoni, Tommaso Bucci, Nicholas Cocomello, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Marcello Dallio, Mario Romeo, Filadelfo Nardo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 761-761
Open Access | Times Cited: 1
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
Mario Romeo, Marcello Dallio, Carmine Napolitano, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 252-252
Open Access | Times Cited: 1
Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study
Haojie Li, Zhan Shi, Xuejiao Chen, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1685-1696
Open Access | Times Cited: 17
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
Inha Jung, Dae-Jeong Koo, Won‐Young Lee
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 327-339
Open Access | Times Cited: 6
The Impact and Burden of Dietary Sugars on the Liver
Helaina Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 14
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Quercetin potentiates the hepatoprotective effect of sildenafil and/or pentoxifylline against intrahepatic cholestasis: Role of Nrf2/ARE, TLR4/NF-κB, and NLRP3/IL-1β signaling pathways
Michael Atef Fawzy, Gehad Nasr, Fares E.M. Ali, et al.
Life Sciences (2022) Vol. 314, pp. 121343-121343
Open Access | Times Cited: 21
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5178-5178
Open Access | Times Cited: 12
The Loge GDR Was Strongly Associated with NAFLD as a Predictor in Normoalbuminuric Patients with Type 2 Diabetes
Baolan Ji, Guanqi Gao, Hongyan Zhao, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 115-124
Open Access
The effect of longitudinal trajectories of triglyceride-glucose index on the new-onset non-alcoholic fatty liver disease
Xiaofeng Wu, Quan Chen, Caiqin Zhang, et al.
(2025)
Closed Access
The clinical value of serum sirtuin-1 concentration in the diagnosis of metabolic dysfunction-associated steatotic liver disease
Farshad Amirkhizi, Mahdiyeh Taghizadeh, Banafshe Khalese-Ranjbar, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
Pirangi Srikanth, Khaja Moinuddin Shaik, Vijay Patibandla, et al.
(2025) Vol. 2
Open Access
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Influence of triglycerides on the link between gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in nonobese Chinese adults: A secondary cohort study
Aihua Chen, Cishuang Fu, Haiying Chen
Medicine (2025) Vol. 104, Iss. 15, pp. e42078-e42078
Open Access
Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
Nuria Barbarroja, M. Ruiz-Ponce, L. Cuesta-López, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
The Role of the Stress Response in Metabolic Dysfunction-Associated Fatty Liver Disease: A Psychoneuroendocrineimmunology-Based Perspective
Ilaria Demori, Elena Grasselli
Nutrients (2023) Vol. 15, Iss. 3, pp. 795-795
Open Access | Times Cited: 10
Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach
Miguel Suárez, Raquel Martínez, Ana María Torres, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6489-6489
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top